Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4722745 | 0.83 | CSNK1E (0.36) | CSNK1ECNR2GPR84ALDH1A1GAA | |
| SCHEMBL21101056 | 0.83 | NR1I2 (0.38) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL22819103 | 0.83 | NR1I2 (0.38) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL25866564 | 0.83 | NR1I2 (0.38) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL20098207 | 0.81 | NR1I2 (0.37) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL20372779 | 0.81 | NR1I2 (0.37) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL19198110 | 0.81 | NR1I2 (0.37) | CSNK1EGPR84ALDH1A1GAA | |
| SCHEMBL10367905 | 0.81 | CNR2 (0.38) | CNR2GPR84ALDH1A1FFAR1 | |
| SCHEMBL9019669 | 0.80 | — | — | |
| SCHEMBL4178697 | 0.80 | NR1I2 (0.40) | CSNK1ECNR2GPR84GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1413305-B1 | ARYL (OR HETEROARYL) AZOLYLCARBYNOL DERIVATIVES FOR THE TREATMENT OF URINARY INCONTINENCE | ESTEVE LABOR DR (ES) | 2006-05-31 | — | — | EP | claimed |